Summary of the technology

TILAPIA LAKE VIRUS VACCINES
Project ID : 2-2014-817

Details of the Technology Offer

The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease.
Additional information can be provided upon request.

Project manager

Elisha Natan
Director BD

Project researchers

Eran Bacharach
T.A.U Tel Aviv University, Life Sciences
Cell Research and Immunology

Ran Bachrach
T.A.U Tel Aviv University, Exact Sciences
Geophysics and planetary sciences

Related Keywords

    About RAMOT at Tel Aviv University Ltd.

    Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.

    RAMOT at Tel Aviv University Ltd.

    Never miss an update from RAMOT at Tel Aviv University Ltd.

    Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide

    RAMOT at Tel Aviv University Ltd.

    Send a request for information
    to RAMOT at Tel Aviv University Ltd.

    About Technology Offers

    Technology Offers on Innoget are directly posted
    and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

    Help

    Need help requesting additional information or have questions regarding this Technology Offer?
    Contact Innoget support